Vuno

338220.KQ

17.31 USD

-2.22

-11.37%

Overview

Last close

17.31 usd

Market cap

240.43M usd

52 week high

49.08 usd

52 week low

16.07 usd

Target price

28.61 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

19.7266

Price/Book Value

61.2608

Enterprise Value

270.06M usd

EV/Revenue

15.916

EV/EBITDA

-9.7142

Key financials

Revenue TTM

12.19M usd

Gross Profit TTM

1.37M usd

EBITDA TTM

-9.88M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

29.17B usd

Net debt

5.06B usd

About

Vuno Inc. operates as a medical artificial intelligence (AI) solution development company. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. Its products include BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalities in the fundus of the eye; and LungCT AI, an AI-based pulmonary lung nodule detection and reporting system. The company was founded in 2014 and is headquartered in Seoul, South Korea.